Running News Daily

Boston Marathon finisher receives three-year doping suspension

On Thursday, the Athletics Integrity Unit (AIU) announced the suspension of Kenyan marathoner Maurine Chepkemoi after she tested positive for erythropoietin (EPO) on Nov. 3 during an out-of-competition doping test in Iten, Kenya.

Chepkemoi has a marathon personal best of 2:20:18 from a second-place finish at the 2021 Amsterdam Marathon. Since 2021, she has won the Enschede Marathon in the Netherlands in a course record time of 2:21:10 and finished 16th at the 2022 Berlin Marathon and 31st at the 2023 Boston Marathon in 2:35:25.

The length of her suspension was reduced by one year for admitting to the anti-doping rule violation (ADRV). The automatic period of ineligibility imposed is four years, unless the athlete can demonstrate that the ADRV was not intentional. In Chepkemoi’s case, she accepted her wrongdoing and the charges laid by the AIU, resulting in a three-year ban until Nov. 2026.

In a statement to Canadian Running, Chepkemoi’s agency, Demadonna Athletics, confirmed that their athlete openly admitted to seeking and using EPO.

EPO has been on the World Anti-Doping Prohibited List since the 1990s; it is used to improve endurance performance or to speed up recovery.

Chepkemoi was one of two Kenyan runners suspended for three years by the AIU on Thursday. The other runner was 2:08-marathoner Thomas Kibet. The 27-year-old tested positive for the steroid norandrosterone after a second-place finish at the 2023 Tallinn Marathon in Estonia.

There are currently 73 Kenyan athletes on the AIU’s Global List of Ineligible Persons. The Kenyan government is in the first year of their $25 million dollar five-year campaign to test more athletes and fight against doping in athletics. The AIU is working with the Kenyan Government, Athletics Kenya and the Anti-Doping Agency of Kenya (ADAK) to combat the issue and test more Kenyan athletes.